A Role for Mediator Complex Subunit MED13L in Rb&Sol;E2F-Induced

Total Page:16

File Type:pdf, Size:1020Kb

A Role for Mediator Complex Subunit MED13L in Rb&Sol;E2F-Induced Oncogene (2012) 31, 4709 --4717 & 2012 Macmillan Publishers Limited All rights reserved 0950-9232/12 www.nature.com/onc ORIGINAL ARTICLE A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest SP Angus and JR Nevins The Rb/E2F pathway is deregulated in virtually all human tumors. It is clear that, in addition to Rb itself, essential cofactors required for transcriptional repression and silencing of E2F target genes are mutated or lost in cancer. To identify novel cofactors required for Rb/E2F-mediated inhibition of cell proliferation, we performed a genome-wide short hairpin RNA screen. In addition to several known Rb cofactors, the screen identified components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription. We show that the Mediator complex subunit MED13L is required for Rb/E2F control of cell growth, the complete repression of cell cycle target genes, and cell cycle inhibition. Oncogene (2012) 31, 4709--4717; doi:10.1038/onc.2011.622; published online 16 January 2012 Keywords: tumor suppressor; cell cycle; senescence INTRODUCTION Typically, the levels of CDKN2A are greatly increased, leading to The retinoblastoma tumor suppressor (Rb) is a critical negative the accumulation of active, hypophosphorylated Rb. Senescent regulator of cellular proliferation that is frequently inactivated in cells characteristically exhibit flat-cell morphology and are positive 20 human cancer.1,2 In its active form, Rb binds to the members of for senescence-associated beta-galactosidase (SA-b-gal) activity. 21 the E2F family of transcription factors and either suppresses their Additionally, Narita et al. described the formation of senescence- transactivation function or assembles an active repressor com- associated heterochromatic foci at E2F promoters during V12 plex.3 E2F family members are essential regulators of genes Ras -induced senescence. Overexpression of the adenoviral required for DNA replication and mitosis.4--6 The transcriptional E1A protein, which targets Rb and its related family members, repression functions of Rb/E2F complexes have been shown to bypassed the senescent phenotype, alleviated E2F target gene reflect the recruitment of transcriptional co-repressors.3,7 --12 In this repression, and blocked the formation of senescence-associated manner, multi-protein transcriptional repressor complexes are heterochromatic foci. The evidence for senescence as a relevant 15,22 --24 guided to specific genes via the E2F binding sites in target gene tumor-suppressive mechanism in vivo is compelling. promoters. Multiple independent investigators have observed senescence The ability of Rb to bind stably to E2F is regulated by markers in premalignant murine lesions induced by activated 25 --29 phosphorylation. In response to mitogenic stimuli in G0, cyclin oncogenes. Furthermore, human benign melanocytic nevi, D/CDK4/6 complexes initiate the phosphorylation of Rb and premalignant lesions in the development of melanoma, possess 29 disrupt Rb/E2F interactions.1,5,6 The alleviation of Rb-mediated multiple characteristics of a senescent phenotype. The loss of repression of E2F enables activated transcription of requisite cell cooperating factors required for transcriptional repression and cycle genes and passage through the G1 --S transition. Deregulated heterochromatin formation initiated by Rb/E2F complexes could Rb/E2F control of cell proliferation is a common feature of cancer represent a mechanism for the progression from benign neoplasia and is underscored by the multitude of observed lesions in human to more advanced malignancies. Here, we performed a genome- tumors.1,2,6 Loss of Rb, loss of the CDK4/6 inhibitor, CDKN2A, and wide short hairpin RNA (shRNA) screen to identify factors critical in amplification/overexpression of CDK4 or cyclin D are examples of the induction and maintenance of the Rb/E2F-induced growth disruptions of cell growth control seen in human tumors. arrest state. Importantly, the loss of key mediators of transcriptional repression and gene silencing has also been shown to confer resistance to Rb/E2F-mediated cell cycle arrest and have been observed in RESULTS human tumors.13,14 A screen for Rb/E2F cofactors that maintain cell cycle arrest Previous studies from multiple independent laboratories have and senescence induction clearly implicated the Rb/E2F pathway in the maintenance of a In an effort to identify essential cofactors in the maintenance of stable cell cycle arrest state and the senescent phenotype in Rb/E2F-mediated cellular senescence, an allele of the large pocket 15 human cells. Cellular senescence was initially observed as a domain of Rb (amino acids 379--928) that harbors mutations in 16 barrier limiting the proliferative capacity of cells in culture. In critical serine and threonine residues, and is thereby refractory cultured human cells, the erosion of telomeres at chromosome to CDK phosphorylation and inactivation (phosphorylation-site ends leads to a p53-dependent response that arrests cell cycle mutant-Rb, PSM-Rb) was expressed in the T98G glioblastoma cell 15,17,18 progression. In addition to telomere shortening, senescence line via retroviral transduction. The large pocket domain of Rb has has been shown to be induced by oncogenic signaling, been demonstrated to be the minimal domain required for E2F 15,19 non-telomeric DNA damage and other cellular stresses. binding and growth suppression, and for tumor suppression in Duke Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, NC, USA. Correspondence: Dr JR Nevins, Duke Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, NC 27710, USA. E-mail: [email protected] Received 19 June 2011; revised and accepted 29 November 2011; published online 16 January 2012 MED13L requirement for Rb/E2F function SP Angus and JR Nevins 4710 100 SA-β-gal 80 pQCXIH pQCXIH-PSM-Rb 60 40 20 BrdU positive (%) 0 pQCXIH pQCXIH- PSM-Rb shLuc shLuc shPool 7 days 19 days post-infection post-infection pQCXIH pQCXIH-PSM-Rb pQCXIH-empty pQCXIH-PSM-Rb Identify shRNA clones shLuc shLuc Figure 1. shRNA screen design: active Rb expression induces stable cell cycle arrest and senescent phenotype. (a) T98G glioblastoma cells expressing the murine ecotropic receptor (T98G-EcoR) were infected with empty retrovirus or retrovirus producing a PSM-Rb. Three days post selection in hygromycin, cells were labeled with BrdU for 16 h, fixed, and BrdU incorporation was detected by immunofluorescence. At least 200 cells were counted per condition. Bar graphs represent mean±s.d. from two independent experiments for PSM-Rb. (b) T98G-EcoR cells treated as in (a) were stained to detect SA-beta-galatosidase activity. (c) The shRNA screen was designed to identify cells resistant to PSM-Rb expression in the shPool populations as compared with the control, shLuc (luciferase). (d) T98G-EcoR cells stably producing shRNA targeting firefly luciferase were infected with empty retrovirus or retrovirus producing PSM-Rb. Either 7 days (empty retrovirus) or 19 days (PSM-Rb retrovirus) post selection in hygromycin, dishes were fixed in methanol, stained with crystal violet and images were captured. mouse models.30,31 Previous studies have demonstrated that this luciferase (shLuc) formed very few colonies upon PSM-Rb mutant form of Rb represses transcription of E2F target genes and introduction compared with control retrovirus (Figure 1d). strongly enforces cell cycle arrest.32,33 Indeed, cells infected with Following the infection of T98G-EcoR populations harboring PSM-Rb-producing retrovirus fail to undergo DNA replication, as pools of shRNA clones, cells were selected with hygromycin measured by 5-bromo-2-deoxyuridine (BrdU) incorporation when for 19--21 days. As shown in Figure 2a, the proliferation of shLuc compared with control cells (Figure 1a). Consistent with prior cells was inhibited, whereas colony outgrowth could be observed observations, chronic PSM-Rb expression elicited stable growth more readily in the pooled shRNA populations. Cells were arrest and characteristics of the senescent phenotype. After 7 days harvested from each shRNA pool population, and genomic of hygromycin selection, population of cells expressing PSM-Rb DNA was prepared. PCR was performed to amplify candidate display a flat-cell morphology and are positive for SA-b-gal activity shRNAs and the resultant fragments were cloned and sequenced. (Figure 1b). In all, 20--30 sequencing reactions were performed from Based on the stability of the arrest state induced by PSM-Rb each shRNA pool (Figure 2b) and 292 specific candidate gene expression, we designed a protocol for a genome-wide shRNA targets were identified by Human BLAT Search of the UCSC screen to identify factors required for the induction and Genome Browser (http://www.genome.ucsc.edu; Supplementary maintenance of the arrest phenotype (Figure 1c). The retroviral Table 1). vector, pQCXIH, produces PSM-Rb and the hygromycin-resistance gene on a bicistronic transcript, ensuring that hygromycin- resistant cells have not lost PSM-Rb expression. The use of the Validation of the screen: identification of E2F5 PSM-Rb allele was intended to reduce the complexity of hits from With the expectation that the candidate genes included false the screen by (1) eliminating factors that might affect Rb positives, we initially sought to validate genes known to function phosphorylation, thereby targeting components of the active in the Rb/E2F pathway. Confirming the success of the
Recommended publications
  • A Pathogenic Ctbp1 Missense Mutation Causes Altered Cofactor Binding and Transcriptional Activity
    neurogenetics (2019) 20:129–143 https://doi.org/10.1007/s10048-019-00578-1 ORIGINAL ARTICLE A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity David B. Beck1 & T. Subramanian2 & S. Vijayalingam2 & Uthayashankar R. Ezekiel3 & Sandra Donkervoort4 & Michele L. Yang5 & Holly A. Dubbs6 & Xilma R. Ortiz-Gonzalez7 & Shenela Lakhani8 & Devorah Segal9 & Margaret Au10 & John M. Graham Jr10 & Sumit Verma11 & Darrel Waggoner12 & Marwan Shinawi13 & Carsten G. Bönnemann4 & Wendy K. Chung14 & G. Chinnadurai2 Received: 23 October 2018 /Revised: 18 March 2019 /Accepted: 9 April 2019 /Published online: 30 April 2019 # Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract We previously reported a pathogenic de novo p.R342W mutation in the transcriptional corepressor CTBP1 in four independent patients with neurodevelopmental disabilities [1]. Here, we report the clinical phenotypes of seven additional individuals with the same recurrent de novo CTBP1 mutation. Within this cohort, we identified consistent CtBP1-related phenotypes of intellectual disability, ataxia, hypotonia, and tooth enamel defects present in most patients. The R342W mutation in CtBP1 is located within a region implicated in a high affinity-binding cleft for CtBP-interacting proteins. Unbiased proteomic analysis demonstrated reduced interaction of several chromatin-modifying factors with the CtBP1 W342 mutant. Genome-wide transcriptome analysis in human glioblastoma cell lines expressing -CtBP1 R342 (wt) or W342 mutation revealed changes in the expression profiles of genes controlling multiple cellular processes. Patient-derived dermal fibroblasts were found to be more sensitive to apoptosis during acute glucose deprivation compared to controls. Glucose deprivation strongly activated the BH3-only pro-apoptotic gene NOXA, suggesting a link between enhanced cell death and NOXA expression in patient fibroblasts.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Noelia Díaz Blanco
    Effects of environmental factors on the gonadal transcriptome of European sea bass (Dicentrarchus labrax), juvenile growth and sex ratios Noelia Díaz Blanco Ph.D. thesis 2014 Submitted in partial fulfillment of the requirements for the Ph.D. degree from the Universitat Pompeu Fabra (UPF). This work has been carried out at the Group of Biology of Reproduction (GBR), at the Department of Renewable Marine Resources of the Institute of Marine Sciences (ICM-CSIC). Thesis supervisor: Dr. Francesc Piferrer Professor d’Investigació Institut de Ciències del Mar (ICM-CSIC) i ii A mis padres A Xavi iii iv Acknowledgements This thesis has been made possible by the support of many people who in one way or another, many times unknowingly, gave me the strength to overcome this "long and winding road". First of all, I would like to thank my supervisor, Dr. Francesc Piferrer, for his patience, guidance and wise advice throughout all this Ph.D. experience. But above all, for the trust he placed on me almost seven years ago when he offered me the opportunity to be part of his team. Thanks also for teaching me how to question always everything, for sharing with me your enthusiasm for science and for giving me the opportunity of learning from you by participating in many projects, collaborations and scientific meetings. I am also thankful to my colleagues (former and present Group of Biology of Reproduction members) for your support and encouragement throughout this journey. To the “exGBRs”, thanks for helping me with my first steps into this world. Working as an undergrad with you Dr.
    [Show full text]
  • Functional Diversification of the Nleg Effector Family in Enterohemorrhagic Escherichia Coli
    Functional diversification of the NleG effector family in enterohemorrhagic Escherichia coli Dylan Valleaua, Dustin J. Littleb, Dominika Borekc,d, Tatiana Skarinaa, Andrew T. Quailea, Rosa Di Leoa, Scott Houlistone,f, Alexander Lemake,f, Cheryl H. Arrowsmithe,f, Brian K. Coombesb, and Alexei Savchenkoa,g,1 aDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada; bDepartment of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4K1, Canada; cDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390; dDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390; ePrincess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G 2M9, Canada; fDepartment of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; and gDepartment of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB T2N 4N1, Canada Edited by Ralph R. Isberg, Howard Hughes Medical Institute and Tufts University School of Medicine, Boston, MA, and approved August 15, 2018 (receivedfor review November 6, 2017) The pathogenic strategy of Escherichia coli and many other gram- chains. Depending on the length and nature of the polyubiquitin negative pathogens relies on the translocation of a specific set of chain, it posttranslationally regulates the target protein’s locali- proteins, called effectors, into the eukaryotic host cell during in- zation, activation, or degradation. Ubiquitination is a multistep fection. These effectors act in concert to modulate host cell pro- process which begins with the ubiquitin-activating enzyme (E1) cesses in favor of the invading pathogen. Injected by the type III using ATP to “charge” ubiquitin, covalently binding the ubiquitin secretion system (T3SS), the effector arsenal of enterohemorrhagic C terminus by a thioester linkage.
    [Show full text]
  • A Genome-Wide Transcriptomic Analysis of Embryos Fathered By
    www.nature.com/scientificreports OPEN A genome‑wide transcriptomic analysis of embryos fathered by obese males in a murine model of diet‑induced obesity Laura Bernhardt1, Marcus Dittrich1,2, Rabih El‑Merahbi3, Antoine‑Emmanuel Saliba4, Tobias Müller2, Grzegorz Sumara3,5, Jörg Vogel4,6, Stefanie Nichols‑Burns7,8, Megan Mitchell7,9, Thomas Haaf1 & Nady El Hajj1,10* Paternal obesity is known to have a negative impact on the male’s reproductive health as well as the health of his ofspring. Although epigenetic mechanisms have been implicated in the non‑ genetic transmission of acquired traits, the efect of paternal obesity on gene expression in the preimplantation embryo has not been fully studied. To this end, we investigated whether paternal obesity is associated with gene expression changes in eight‑cell stage embryos fathered by males on a high‑fat diet. We used single embryo RNA‑seq to compare the gene expression profle of embryos generated by males on a high fat (HFD) versus control (CD) diet. This analysis revealed signifcant upregulation of the Samd4b and Gata6 gene in embryos in response to a paternal HFD. Furthermore, we could show a signifcant increase in expression of both Gata6 and Samd4b during diferentiation of stromal vascular cells into mature adipocytes. These fndings suggest that paternal obesity may induce changes in the male germ cells which are associated with the gene expression changes in the resulting preimplantation embryos. Global obesity rates have more than doubled over the past three decades1. Despite increasing recognition of the problem, the prevalence of obesity is rising in most countries worldwide.
    [Show full text]
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor
    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
    [Show full text]
  • A Mechanism of COOH–Terminal Binding Protein– Mediated Repression
    A Mechanism of COOH–Terminal Binding Protein– Mediated Repression Alison R. Meloni,1 Chun-Hsiang Lai,2 Tso-Pang Yao,2 and Joseph R. Nevins1,3 Departments of 1Molecular Genetics and Microbiology and 2Pharmacology and Cancer Biology and 3Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina Abstract repression involves the recruitment of histone deacetylase The E2F4 and E2F5 proteins specifically associate with (HDAC) to E2F site–containing promoters, presumably the Rb-related p130 protein in quiescent cells to repress resulting in an alteration of chromatin conformation that transcription of various genes encoding proteins hinders transcription (7-9). important for cell growth. A series of reports has Several observations suggest that additional events, inde- provided evidence that Rb-mediated repression involves pendent of HDAC recruitment, may contribute to the both histone deacetylase (HDAC)–dependent and repression. For example, many genes subject to E2F/Rb- HDAC-independent events. Our previous results mediated repression are not derepressed by treatment with the suggest that one such mechanism for Rb-mediated HDAC inhibitor trichostatin A (7). Moreover, Rb mutants that repression, independent of recruitment of HDAC, can no longer interact with HDAC are still capable of repressing involves the recruitment of the COOH-terminal binding transcription (10, 11). Based on these observations, it would protein (CtBP) corepressor, a protein now recognized to seem that HDAC-independent mechanisms of transcriptional play a widespread role in transcriptional repression. We repression contribute to the Rb control of transcription. Indeed, now find that CtBP can interact with the histone several Rb-interacting proteins, such as the chromatin remodel- acetyltransferase, cyclic AMP–responsive element– ing complex proteins BRG1 and human BRM, the methyl- binding protein (CREB) binding protein, and inhibit its transferase protein SUV39H1, and RBP1, have been shown to ability to acetylate histone.
    [Show full text]
  • FBXL19 Recruits CDK-Mediator to Cpg Islands of Developmental Genes Priming Them for Activation During Lineage Commitment
    RESEARCH ARTICLE FBXL19 recruits CDK-Mediator to CpG islands of developmental genes priming them for activation during lineage commitment Emilia Dimitrova1, Takashi Kondo2†, Angelika Feldmann1†, Manabu Nakayama3, Yoko Koseki2, Rebecca Konietzny4‡, Benedikt M Kessler4, Haruhiko Koseki2,5, Robert J Klose1* 1Department of Biochemistry, University of Oxford, Oxford, United Kingdom; 2Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; 3Department of Technology Development, Kazusa DNA Research Institute, Kisarazu, Japan; 4Nuffield Department of Medicine, TDI Mass Spectrometry Laboratory, Target Discovery Institute, University of Oxford, Oxford, United Kingdom; 5CREST, Japan Science and Technology Agency, Kawaguchi, Japan Abstract CpG islands are gene regulatory elements associated with the majority of mammalian promoters, yet how they regulate gene expression remains poorly understood. Here, we identify *For correspondence: FBXL19 as a CpG island-binding protein in mouse embryonic stem (ES) cells and show that it [email protected] associates with the CDK-Mediator complex. We discover that FBXL19 recruits CDK-Mediator to †These authors contributed CpG island-associated promoters of non-transcribed developmental genes to prime these genes equally to this work for activation during cell lineage commitment. We further show that recognition of CpG islands by Present address: ‡Agilent FBXL19 is essential for mouse development. Together this reveals a new CpG island-centric Technologies, Waldbronn, mechanism for CDK-Mediator recruitment to developmental gene promoters in ES cells and a Germany requirement for CDK-Mediator in priming these developmental genes for activation during cell lineage commitment. Competing interests: The DOI: https://doi.org/10.7554/eLife.37084.001 authors declare that no competing interests exist.
    [Show full text]
  • Structure and Mechanism of the RNA Polymerase II Transcription Machinery
    Downloaded from genesdev.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Structure and mechanism of the RNA polymerase II transcription machinery Allison C. Schier and Dylan J. Taatjes Department of Biochemistry, University of Colorado, Boulder, Colorado 80303, USA RNA polymerase II (Pol II) transcribes all protein-coding ingly high resolution, which has rapidly advanced under- genes and many noncoding RNAs in eukaryotic genomes. standing of the molecular basis of Pol II transcription. Although Pol II is a complex, 12-subunit enzyme, it lacks Structural biology continues to transform our under- the ability to initiate transcription and cannot consistent- standing of complex biological processes because it allows ly transcribe through long DNA sequences. To execute visualization of proteins and protein complexes at or near these essential functions, an array of proteins and protein atomic-level resolution. Combined with mutagenesis and complexes interact with Pol II to regulate its activity. In functional assays, structural data can at once establish this review, we detail the structure and mechanism of how enzymes function, justify genetic links to human dis- over a dozen factors that govern Pol II initiation (e.g., ease, and drive drug discovery. In the past few decades, TFIID, TFIIH, and Mediator), pausing, and elongation workhorse techniques such as NMR and X-ray crystallog- (e.g., DSIF, NELF, PAF, and P-TEFb). The structural basis raphy have been complemented by cryoEM, cross-linking for Pol II transcription regulation has advanced rapidly mass spectrometry (CXMS), and other methods. Recent in the past decade, largely due to technological innova- improvements in data collection and imaging technolo- tions in cryoelectron microscopy.
    [Show full text]
  • Gene Ontology Functional Annotations and Pleiotropy
    Network based analysis of genetic disease associations Sarah Gilman Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2013 Sarah Gilman All Rights Reserved ABSTRACT Network based analysis of genetic disease associations Sarah Gilman Despite extensive efforts and many promising early findings, genome-wide association studies have explained only a small fraction of the genetic factors contributing to common human diseases. There are many theories about where this “missing heritability” might lie, but increasingly the prevailing view is that common variants, the target of GWAS, are not solely responsible for susceptibility to common diseases and a substantial portion of human disease risk will be found among rare variants. Relatively new, such variants have not been subject to purifying selection, and therefore may be particularly pertinent for neuropsychiatric disorders and other diseases with greatly reduced fecundity. Recently, several researchers have made great progress towards uncovering the genetics behind autism and schizophrenia. By sequencing families, they have found hundreds of de novo variants occurring only in affected individuals, both large structural copy number variants and single nucleotide variants. Despite studying large cohorts there has been little recurrence among the genes implicated suggesting that many hundreds of genes may underlie these complex phenotypes. The question
    [Show full text]
  • Supp Table 6.Pdf
    Supplementary Table 6. Processes associated to the 2037 SCL candidate target genes ID Symbol Entrez Gene Name Process NM_178114 AMIGO2 adhesion molecule with Ig-like domain 2 adhesion NM_033474 ARVCF armadillo repeat gene deletes in velocardiofacial syndrome adhesion NM_027060 BTBD9 BTB (POZ) domain containing 9 adhesion NM_001039149 CD226 CD226 molecule adhesion NM_010581 CD47 CD47 molecule adhesion NM_023370 CDH23 cadherin-like 23 adhesion NM_207298 CERCAM cerebral endothelial cell adhesion molecule adhesion NM_021719 CLDN15 claudin 15 adhesion NM_009902 CLDN3 claudin 3 adhesion NM_008779 CNTN3 contactin 3 (plasmacytoma associated) adhesion NM_015734 COL5A1 collagen, type V, alpha 1 adhesion NM_007803 CTTN cortactin adhesion NM_009142 CX3CL1 chemokine (C-X3-C motif) ligand 1 adhesion NM_031174 DSCAM Down syndrome cell adhesion molecule adhesion NM_145158 EMILIN2 elastin microfibril interfacer 2 adhesion NM_001081286 FAT1 FAT tumor suppressor homolog 1 (Drosophila) adhesion NM_001080814 FAT3 FAT tumor suppressor homolog 3 (Drosophila) adhesion NM_153795 FERMT3 fermitin family homolog 3 (Drosophila) adhesion NM_010494 ICAM2 intercellular adhesion molecule 2 adhesion NM_023892 ICAM4 (includes EG:3386) intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)adhesion NM_001001979 MEGF10 multiple EGF-like-domains 10 adhesion NM_172522 MEGF11 multiple EGF-like-domains 11 adhesion NM_010739 MUC13 mucin 13, cell surface associated adhesion NM_013610 NINJ1 ninjurin 1 adhesion NM_016718 NINJ2 ninjurin 2 adhesion NM_172932 NLGN3 neuroligin
    [Show full text]